Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer

INTRODUCTION: The aim of this study was to investigate the treatment and prognosis of advanced non-small cell lung cancer (NSCLC) patients after failure of long-term treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). MATERIAL AND METHODS: We retrospectively analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhengbo, Zhang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754371/
https://www.ncbi.nlm.nih.gov/pubmed/26925125
http://dx.doi.org/10.5114/aoms.2016.57586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754371/
https://www.ncbi.nlm.nih.gov/pubmed/26925125
http://dx.doi.org/10.5114/aoms.2016.57586

Ejemplares similares